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Introduction: Previous research had shown the suitability of several questionnaires pre-
dicting the obstructive sleep apnea syndrome. Measurement properties of an online
screening questionnaire were studied.
Methods: The sample consisted of 184 Portuguese adults (89 men and 95 women); 46 of
them were polysomnographically diagnosed with the untreated obstructive sleep apnea
syndrome. The participants were assessed with an online questionnaire of sleep apnea
risk, from University of Maryland.
Results: A principal component factor analysis was performed, revealing a single factor
(49.24% of the total variance). Internal consistency was minimally adequate (α¼0.74).
The mean of inter-item correlation was of 0.35 (0.12or40.61), whereas the item-total
correlations were considered good (0.52or40.81). The total score for patients was
signiﬁcantly higher than for healthy participants (po0.000), but no signiﬁcant statistical
differences between severity groups of patients were found (p40.05).
Furthermore, the ability of the measure in discriminating between healthy subjects and
OSA subjects was good. Overall data from the Rasch analysis was consistent with the
guidelines of Linacre, scores show good model ﬁt and psychometric adequacy.
Conclusions: The measure showed an adequate structural, internal and criterion validity,
suggesting this as a useful and effective screening for sleep apnea risk in Portuguese adults.
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access article under the CC BY-NC-ND license
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The Obstructive Sleep Apnea Syndrome (OSAS) [1] is a
breathing-related sleep disorder whose prevalence rates
appear to be consistent in different populations. A review
[2] of research studies from the United States and Europe has
indicated a prevalence of 1–5 Caucasian adults (25–28 kg/m2
of body mass) have an apnea–hypopnea index (AHI) over 5
(mild severity), and 1–15 Caucasian adults have an AHI over
15 (moderate severity). In line with these ﬁndings, it is
suggested that adults in Western countries have a 5% prob-
ability of suffering from OSAS. Comparing the incidence of
OSAS among Western and Eastern countries [3], the rates
vary from 3.5% (Australia) to 7.5% (India) for men, whereas for
women these values ranged from 1.2% (US) to 4.5% (India).
However, 93% of women and 82% of men with moderate to
severe OSA are not properly diagnosed [4]. Furthermore, the
available data on OSAS allows the identiﬁcation of the following
risk proﬁle: male gender (2–3/1), obesity and aging (30–60 years
old, increasing in third age), which aremore likely to increase the
incidence rates in women after menopause [1,5–11].
The diagnosis of OSAS is one of the key problems in this
ﬁeld. Although polysomnography is considered as the gold
standard for the diagnosis of OSAS [1], this method is not yet
widely available due, probably, to its high cost. Thus, some
attempts have been made to develop self-report measures
based on symptoms of sleep apnea (e.g., excessive daytime
sleepiness, periods of stopping breathing during sleep
observed by others), anthropometry (e.g., body mass index,
overweight, neck circumference), demographics (gender and
age) and the presence of major comorbidities (e.g., blood
pressure, stroke), to screening OSAS's risk. Among the most
used screening questionnaires are the Epworth Sleepiness
Scale [12], the Berlin Questionnaire [13], the STOP [14], the
STOP-Bang [15] and the ASA checklist [16].
A systematic review [17] suggests that STOP and STOP-Bang
questionnaires for screening of OSAS in the surgical population
are more suitable due to their higher methodological quality and
easy-to-use features. On the other hand, a meta-analysis [18]
suggested differences in the screening of OSAS between non-risk
and surgical populations, in which the Berlin Questionnaire and
the Sleep Disorders Questionnaire [19] were considered as
effective means to discriminate these differences regardingTable 1 – Demographical data and AHI.
Healthy subjects Subjects with mild to mo
n¼138 n¼24
Mean SD Mean S
Age 41,55 8,57 57,17 1
AHI –a –a o30
Gender ♂ ♀ ♂ ♀
n(sr) n(sr) n(sr) n
52(1,6) 84(1,5) 20(2,5) 4
OSAS: obstructive sleep apnea syndrome; SD: standard deviation; AHI: a
a No polisonographic study has performed; ♂: masculine; ♀: feminine; sOSAS, whereas morphometry and combined clinical cepha-
lometry were the most accurate clinical models.
The Sleep Disorders Center of the University of Maryland
has developed a screening questionnaire to assess the risk of
OSAS, which is freely available online [20]. This instrument
consists of ﬁve sections (described in the Section Method and
materials), each of them describing the main features of
OSAS, including symptoms observed by the patients or by
others, anthropometric characteristics, daytime sleepiness,
and major comorbidities. Taking into account the clinical
relevance of OSAS and the need to have effective screening
measures for this disorder, our main objective was to study
the measurement properties of a recent scale to assess OSAS,
the Questionnaire of Sleep Apnea Risk (QSAR).
The statistical procedures used to study the effectiveness
of QSAR in screening OSAS were based on the Classical
Measurement Theory (CMT) and Rasch Measurement
Theory (RMT).2. Methods and materials
2.1. Design and procedures
This study is based on a one-shot design. All subjects were
volunteers (not paid) that gave their informed consent to the
study objectives. The study was approved by the scientiﬁc
and ethical committee of the clinical institutions where the
subjects were diagnosed and treated for OSAS.2.2. Participants
The sample consisted of 184 Portuguese adults (89 men and
95 women); 46 of them (35 men and 11 women) were
polysomnographically (type 1) diagnosed with untreated
OSAS, presenting different types of severity (measured by
Apnea–Hypopnea Index [AHI], non-positional). OSAS subjects
were recruited from three public Portuguese hospitals, while
the remaining participants were healthy volunteers without a
clinical diagnosis of OSAS (54 men and 84 women), who were
recruited from a sample community (universities and com-
panies) based on convenience method.derate OSAS Subjects with severe OSAS p
n¼22
D Mean SD
1,14 56 8,9 .000n
430 –
♂ ♀
(sr) n(sr) n(sr)
(2,4) 15(1,3) 7(1,3) .000n
pnea/hipopnea index.
r: standardised residuals.
Fig. 1 – Questionnaire of Sleep Apnea Risk (Medical Centre of University of Maryland).
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form sleeping habits questionnaire, in which healthy partici-
pants reported not having any diagnosis or symptoms of
sleeping disturbances and overweight. Due to high cost and
unavailability of most volunteers, polysomnography was not
performed to these participants. They were included only if
they scored below 9 in the Epworth Sleepiness Scale [12,21].
None of the subjects assessed (healthy and OSAS subjects)
was a shift worker, had clinical history of any neurological or
psychiatric disorders, or was doing any type of psychotropic
medication.
Table 1 shows the basic demographic characteristics of the
sample, as well as the AHI for the clinical sample of OSAS.
The comparisons between healthy subjects and OSAS
subjects showed statistically signiﬁcant differences regarding
age. Tukey HSD revealed statistically signiﬁcant differences
between healthy participants and OSAS subjects, but not
between the groups of different OSAS severity. As for the
gender distribution, standardized residuals showed a differ-
ence in the gender distribution, particularly in subjects
diagnosed with mild to moderate OSAS.2.3. Materials
2.3.1. Clinical history
As stated before, a short-form questionnaire was developed
to assess the demographic variables, sleeping habits and if
there was a previously diagnosed sleeping disorder.
2.4. QSAR [20] (Questionnaire of sleep apnea risk; Medical
Centre of University of Maryland)
The QSAR, from University of Maryland, consists in 5 items
(including the symptoms observed by the patient and by
others, anthropometric characteristics, Epworth Sleepiness
Scale score and major comorbidities), as shown in Fig. 1.
The four initial items of the scale are scored from 1(a) to 4(d),
whereas item ﬁve ‘previous medical history’ is scored from 1
(none), 2 (1 previous clinical condition), 3 (2–3 previous clinical
conditions), and 4 (Z4 clinical conditions). The total score is
computed through the sum of item responses and represents a
measure of sleep apnea risk (ranged 5–20, higher results
indicate greater sleep apnea risk).
Table 4 – Descriptives for QSAR total score.
Healthy
subjects
Subjects with
mild to moderate
OSA
Subjects with
severe OSA
n¼138 n¼24 n¼22
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The Epworth Sleepiness Scale consists of 8 items, rated on a
scale of 0–3, in which the total score is computed through the
sum of item responses. The total score represents a measure
of subjective daytime sleepiness (ranged 0–24, higher results
indicate greater propensity to fall asleep).Mean SD Mean SD Mean SD
SAR 8,16 2,36 14,25 2,97 13,36 3,54
SD: standard deviation.3. Results
The methods of CMT to assess the effectiveness of the QSAR
were based on descriptive statistics, principal component
factor analysis, inter-item correlations, Cronbach's alpha
and an ANOVA for the comparison between different severity
OSAS patients's groups and healthy participants. Sensitivity
and speciﬁcity were also calculated. These methods were
performed using the SPSS v.20 for Windows.
The item-response theory through RMT was conducted
testing the Linacre guidelines [22]. These analysis were
performed using the Winsteps 3.80.1 [23].
3.1. Classical measurement theory
3.1.1. Descriptive and distribution analysis
Table 2 shows the descriptive statistics for the 5 items and
the total QSAR.
As shown in Table 2, no relevant deviations from Normal
distribution were observed for items (i.e., only two items showed
slightly negative skewness and one item with slightly lower
than normal kurtosis). Descriptive statistics showed that obser-
vations covered the scale range for each individual item. The
number of missing values was negligible from a statistical
standpoint.Table 2 – Descriptives for the ﬁve items and total QSAR
score.
Mean SD Asymetry Curtosis Min/
Max
MV
Item 1 2,33 1,12 0,28 1,29 1/4 0
Item 2 1,64 1,10 1,37 0,19 1/4 1
Item 3 2,09 1,02 0,51 0,91 1/4 1
Item 4 1,52 0,75 1,27 0,84 1/4 1
Item 5 2,02 1,08 0,68 0,85 1/4 0
Total QSAR
score
9,58 3,58 0,83 0,23 4/19 0
SD: Standard Deviation; Min/Max: Minimum/Maximum; MV:
Missing Values.
Table 3 – Component matrix.
Component
Item 1 0.81
Item 2 0.79
Item 3 0.58
Item 4 0.53
Item 5 0.76
Extraction method: principal component analysis.3.1.2. Structural validity
To study the structural validity of the scale, a principal
component factor analysis was performed on the ﬁve items
of the QSAR.
The initial solution was minimal satisfactory [KMO¼0.709,
χ2(10)¼206.479, p¼0.000]. The communalities ranged from
0.38 (for item 4) to.66 (for item 1). From the initial solution,
one single factor was extracted with eigenvalue greater than
1 according to the Kaiser and Guttman rule (eigenvalue:
2.462), explaining 49.24% of scale variance.
Table 3 displays the component matrix loadings for each
item (430) for the one dimension solution.
As shown in Table 3, all items have higher loadings
(40.50) within a single factor. This one-dimensional solution
is suitable to describe our data since it is appropriate to
describe the construct and the underlying factor structure.3.1.3. Internal validity
To study the internal validity of the QSAR, item-total correla-
tions with r Pearson were performed. The results show
moderate to strong positive correlations (0.52or40.81)
between each individual item and the total scale (all
p's¼0.000). Item 4 is the one that has the lowest correlation
with the total scale.3.1.4. Criterion validity
The criterion validity of the QSAR was tested with an ANOVA
was performed to compare subjects diagnosed with different
severity groups OSAS subjects vs. healthy participants in
QSAR total score. Table 4 depicts mean scores and standard
deviations of the QSAR total score in OSAS subjects and
healthy participants.
The comparisons between healthy participants and OSAS
subjects groups showed statistically signiﬁcant differences
regarding QSAR global score [F(2, 181)¼82.169; p¼0.000].
Tukey test revealed statistically signiﬁcant differences
between healthy participants and OSAS subjects, but not
between the groups of different OSAS severities.3.1.5. Reliability
The internal consistency was estimated using Cronbach's
alpha method that was performed to study the reliability of
the QSAR in evaluating sleeping disturbances. The Cron-
bach's alpha (0.74) was acceptable for the version of the
QSAR with the original ﬁve items, even after the possibility of
increasing the alpha level when items were removed.
The average inter-item correlation was r¼0.35 (0.12or40.61),
Fig. 2 – ROC curve for Healthy subjects vs OSAS subjects.
Table 5 – Statistics of QSAR.
Category Observed B Inﬁt Outﬁt Step
1 442 (48%) 1.63 1.14 1.10 –
2 227 (25%) 0.91 0.94 0.97 0.73
3 132 (14%) 0.01 0.99 0.96 0.15
4 119 (13%) 0.98 0.91 0.83 0.59
M (SD)
Item outﬁt 0.98 (0.24)
Person outﬁt 0.98 (0.63)
Item separation reliability 0.96
Person separation reliability 0.59
Cronbach α 0.75
% Items with outﬁt 42 0%
% Persons with outﬁt 42 7.61%
M: mean; SD: standard deviation.
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according to this analysis.3.1.6. Sensitivity and speciﬁcity
The discriminant performance of the QSAR was determined
by observing the Receiver Operating Characteristic Curve
(ROC). The ROC analysis was performed for the total score
of the QSAR. The capability of the scale to distinguish clinical
sample from healthy volunteers is shown in Fig. 2.
The Area Under the Curve (AUC) revealed a good discri-
minant capacity through the total score (AUC¼0.91; 95%
Conﬁdence Interval ranged between 0.86–0.96). The cut-off
score in discriminating among OSAS subjects and healthy
subjects was also estimated under the assumption of max-
imizing the sum of sensitivity and speciﬁcity. The best cut-off
point for the scale was of 10.5, as shown in Fig. 2.3.2. Rasch measurement theory
Results, through RMT, are consistent with the guidelines of
Linacre [22] and all lines of QSAR were overcome successfully.
The score statistics is presented in Table 5.
Model ﬁt is adequate: no item outﬁt is over 2 (severe
misﬁt), the percentage of people with outﬁt over 2 is small
(7.61%) and average outﬁt values, for items and people, are
close to 1 (perfect ﬁt). Furthermore, the score reliability
through Item Separation Reliability value (0.96), Cronbach's
alpha (0.75), was considered high and Person Separation
Reliability value (0.59), indicator that may need more items
in the instrument to distinguish between high and low
performers in the QSAR.
The graphic representation, in Fig. 3, shows the good
functioning of response categories of QSAR, each category
has a real probability of being selected by the sample.4. Discussion
In order to increase variability and to prevent ﬂoor effects, the
statistical analysis was performed for the total sample,
including both healthy participants and OSAS subjects. With
exception of two items that present a slightly asymmetric
distribution, the overall scale distribution is acceptable and
did not show any relevant deviations from Normal distribu-
tion. From a structural validity point-of-view it was possible
to extract an interpretable one-dimensional solution ‘sleep
apnea risk’, which concur with the factor structure of most
questionnaires assessing risk of apnea [12–16].
Moreover, this scale reveals an adequate internal validity,
which is conﬁrmed by moderate to strong correlations
between each of the items and their overall score.
As regards to the criterion validity, the healthy partici-
pants differed from the OSAS subjects, but no signiﬁcant
differences were found between severity levels in OSAS
groups. Interestingly, the subjects diagnosed with mild to
moderate OSAS (AHIo30) showed higher scores on the QSAR
than others with severe OSAS (AHI430). This is unexpected
because the AHI, which is a polysomnographic measure of
OSAS severity, should be strongly and positively associated
with other putative measures (e.g., clinical measures, symp-
tomatic or self-report questionnaires). One possible explana-
tion can be related to the use of new criteria from the AASM
[1] for scoring hypopneas that impact on the AHI [24].
The subjects diagnosed with OSAS that comprise our sample
were recruited in three different hospitals that use distinct
coding systems for hypopneas. On the other hand, it is also
known that mild to moderate AHI (11–30) are more variable
than extreme AHI (very mild or severe), but also that the use
of a single measure of this index in a single polysomnography
session is inaccurate and may bias the classiﬁcation of OSAS
severity [25]. Despite we have used the non-positional AHI,
which is considered as the more reliable indicator (i.e., with
lower variance), it is also known that the percentage of
subjects with high variability in AHI assessed exclusively in
supine position (position favoring respiratory events) [1] is
much higher than that of subjects with high variability in
non-positional AHI (which includes all sleeping positions),
Fig. 3 – Item difﬁculty.
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of night sleep [25]. However, we did not obtain data that allow
assessing the amount of supine position per subject.
Regarding the internal consistency of the total scale,
estimated through the Cronbach's alpha, the obtained results
suggest minimal adequacy of the scale according to Nun-
naly's criteria [26].
We also attempted to study the discriminant capacity of the
QSAR in discriminating OSAS subjects from healthy individuals.
To accomplish this goal, a ROC analysis was conducted on the
total score of the scale. The data indicated a good discriminant
performance of the scale. The cut-off score was also estimated
under the same statistical procedure. The best cut-off point with
adequate level of sensitivity and speciﬁcity in discriminating
subjects with OSAS is of 10.5. The probability of discrimination a
true positive (OSAS; i.e., sensitivity) was, in average, 87%,
whereas the probability of discrimination a true negative (with-
out OSAS; i.e., speciﬁcity) was, in average, 80%. More particularly,
a total score in the QSAR of 10.5 or more may be indicative of
OSAS. The obtained data for sensitivity and speciﬁcity are
encouraging when compared with the most commonly used
screening methods for OSAS [16].
The RMT suggests that the standard version of the QSAR is
consistent with the theory guidelines [22], scores show good
model ﬁt and psychometric adequacy. The main indicators
reveal an adequate adjustment between persons and
measure.
In sum, both the CMT and RMT suggest suitability of the
QSAR to the Portuguese population. The ﬁve items that
comprise main indicators of OSAS (snoring, stopping breath-
ing, overweight, daytime sleepiness and usual comorbid
conditions) can generate relevant information for predictingOSAS in a fast and simple way. Thus, the QSAR (which
includes the Epworth Sleepiness Scale score) provides a
useful and effective tool in the ﬁrst line diagnosis of OSAS
in Portuguese adults.
The main limitations to our conclusions were due to the
polysomnographic assessments. One of these limitations can
be related to differences in the AHI scoring system due to
evaluations that were obtained from different polysomno-
graphic centers, which may have an impact on criterion
validity to a greater extent than on other statistical procedures
in which the overall sample was used. Another limitation that
was already mentioned is related to the lack of polysomno-
graphic assessments in our healthy sample of volunteers that
may have also contributed to false negative rates. Thus, in
future studies, an evaluation in the same center of polysom-
nography is strongly advised to increase coherence in assess-
ment, and, whenever possible, it is also recommended to
include polysomnography for OSAS screening.Conﬂicts of interest
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